Baidu
map

Lancet:新型多源控流深部脑刺激对帕金森病有很好地控制作用

2015-05-30 MedSci MedSci原创

    背景  具有单一电源的高神脑部刺激(DBS)可以有效缓解帕金森症患者的运动症状。研究人员推测,一个多源,恒流装置,允许定义良好的电流分布将改善帕金森症的运动。    方法  研究人员在六个欧洲国家的大学专业DBS研究中心对一个可植入的DBS装置(VANTAGE研究)做了一项前瞻性,多中心,非随机,开放标签干预研究。若患者年龄在21

背景  
具有单一电源的深部脑刺激(DBS)可以有效缓解帕金森症患者的运动症状。研究人员推测,一个多源可控制电流的深部脑刺激装置可能有更好的改善帕金森症的运动。

方法  
研究人员在欧洲六个国家的大专业DBS研究中心对一种新型可植入的DBS装置(VANTAGE研究)做了一项前瞻性,多中心,非随机,开放标签干预研究。若患者年龄在21-75岁,被诊断为双侧特发性帕金森氏病运动症状5年以上,有Hoehn和Yahr评分为2分及以上,并有一个统一的帕金森病评定量表组成部分III(UPDRS III)得分超过30,左旋多巴治疗后提高了33%以上,即有资格参与此项研究。参加者在底丘脑核接受双侧植入一个多源,恒流,八接触,可再充电的DBS系统,并在植入后12,26,和52周进行了评估。主要终点是在后的铅从基线(药物结束状态)到第一次植入后26周(刺激开始,用药结束状态)的UPDRS III得分(通过知道治疗分配的现场调查员进行评估)平均变化。

结果  53例患者参加了这项研究,40例接受了双侧丘脑底核深部电刺激植入,以及完成了主要终点的分析。与基线相比(37.4 [8.9] ,34.5–40.2),第一次植入术后6个月的UPDRS III运动评分有所改进(平均13.5 [SD 6.8] 95% Cl 11.3–15.7),有23.8平均差(SD 10.6;95% Cl 20.3–27.3;P<0.0001)。一名患者在植入24周后死于肺炎,这被认为是和治疗程序无关的死亡。 125例不良事件被报道,其中最常见的都是肌张力障碍,言语障碍,和冷漠。 18例严重不良事件被记录,其中三例是由于该设备或程序引起的(感染,迁移和呼吸抑制各1例)。在研究过程中所有严重不良事件无残留效应和刺激仍然存在。

结论  
这个多个源,可控流的深部脑刺激装置可以有效地控制帕金森病患者的运动症状,同时,也有较好的安全性和耐受性。但是,仍然需要更多的试验来对该系统的术后效果的潜在好处及其副作用进行研究。

原始出处:
Prof Lars Timmermann, MDcorrespondenceemail, Roshini Jain, MS, Lilly Chen, PhD, Mohamed Maarouf, MD, Michael T Barbe, MD, Niels Allert, MD, Prof Thomas Brücke, MD, Iris Kaiser, MD, Sebastian Beirer, MD, Fernando Sejio, MD, Esther Suarez, MD, Beatriz Lozano, MD, Claire Haegelen, PhD, Prof Marc Vérin, MD, Mauro Porta, MD, Domenico Servello, MD, Prof Steven Gill, MS, Alan Whone, FRCP, Nic Van Dyck, RN, Prof Francois Alesch, MD,Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson's disease (the VANTAGE study),Lancet,2015.5.28

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1828126, encodeId=aee318281262d, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Feb 14 00:53:00 CST 2016, time=2016-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=28820, encodeId=f5c72882060, content=进步, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Thu Jun 25 09:42:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457654, encodeId=179e145e654ff, content=<a href='/topic/show?id=f9f684e27d6' target=_blank style='color:#2F92EE;'>#脑刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84727, encryptionId=f9f684e27d6, topicName=脑刺激)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Mon Jun 01 00:53:00 CST 2015, time=2015-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25490, encodeId=000c25490c2, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 31 20:46:00 CST 2015, time=2015-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25406, encodeId=8e4b2540671, content=这是对深部脑刺激治疗的改进, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sat May 30 14:17:00 CST 2015, time=2015-05-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1828126, encodeId=aee318281262d, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Feb 14 00:53:00 CST 2016, time=2016-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=28820, encodeId=f5c72882060, content=进步, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Thu Jun 25 09:42:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457654, encodeId=179e145e654ff, content=<a href='/topic/show?id=f9f684e27d6' target=_blank style='color:#2F92EE;'>#脑刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84727, encryptionId=f9f684e27d6, topicName=脑刺激)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Mon Jun 01 00:53:00 CST 2015, time=2015-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25490, encodeId=000c25490c2, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 31 20:46:00 CST 2015, time=2015-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25406, encodeId=8e4b2540671, content=这是对深部脑刺激治疗的改进, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sat May 30 14:17:00 CST 2015, time=2015-05-30, status=1, ipAttribution=)]
    2015-06-25 nizongzan

    进步

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1828126, encodeId=aee318281262d, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Feb 14 00:53:00 CST 2016, time=2016-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=28820, encodeId=f5c72882060, content=进步, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Thu Jun 25 09:42:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457654, encodeId=179e145e654ff, content=<a href='/topic/show?id=f9f684e27d6' target=_blank style='color:#2F92EE;'>#脑刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84727, encryptionId=f9f684e27d6, topicName=脑刺激)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Mon Jun 01 00:53:00 CST 2015, time=2015-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25490, encodeId=000c25490c2, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 31 20:46:00 CST 2015, time=2015-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25406, encodeId=8e4b2540671, content=这是对深部脑刺激治疗的改进, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sat May 30 14:17:00 CST 2015, time=2015-05-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1828126, encodeId=aee318281262d, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Feb 14 00:53:00 CST 2016, time=2016-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=28820, encodeId=f5c72882060, content=进步, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Thu Jun 25 09:42:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457654, encodeId=179e145e654ff, content=<a href='/topic/show?id=f9f684e27d6' target=_blank style='color:#2F92EE;'>#脑刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84727, encryptionId=f9f684e27d6, topicName=脑刺激)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Mon Jun 01 00:53:00 CST 2015, time=2015-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25490, encodeId=000c25490c2, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 31 20:46:00 CST 2015, time=2015-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25406, encodeId=8e4b2540671, content=这是对深部脑刺激治疗的改进, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sat May 30 14:17:00 CST 2015, time=2015-05-30, status=1, ipAttribution=)]
    2015-05-31 huaxipanxing

    看看

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1828126, encodeId=aee318281262d, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Feb 14 00:53:00 CST 2016, time=2016-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=28820, encodeId=f5c72882060, content=进步, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Thu Jun 25 09:42:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457654, encodeId=179e145e654ff, content=<a href='/topic/show?id=f9f684e27d6' target=_blank style='color:#2F92EE;'>#脑刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84727, encryptionId=f9f684e27d6, topicName=脑刺激)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Mon Jun 01 00:53:00 CST 2015, time=2015-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25490, encodeId=000c25490c2, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 31 20:46:00 CST 2015, time=2015-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25406, encodeId=8e4b2540671, content=这是对深部脑刺激治疗的改进, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sat May 30 14:17:00 CST 2015, time=2015-05-30, status=1, ipAttribution=)]
    2015-05-30 lovetcm

    这是对深部脑刺激治疗的改进

    0

相关资讯

Move Disor:新型血液检测诊断早期帕金森

近日,一篇发表于国际杂志Movement Disorders上的研究论文中,来自西奈山医疗中心(Mount Sinai Medical Center)的研究人员通过研究开发了一种新型血液检测手段,其或许可以准确鉴别出帕金森疾病发病的血液标记或生物标志物;相关研究成果或为开发寻找新型生物标志物的新方法来帮助预测个体是否患帕金森疾病带来一定的帮助。文章中,研究者分析了四组小鼠的血样以此来形成帕金森疾病

宣武医院陈彪:苹果公司为何找上门来合作帕金森病?

苹果在昨日凌晨的发布会上,推出了全新的医疗应用ResearchKit。在这场万里之外的新闻发布会上,却意外地出现了一家中国医疗机构的LOGO,这正是首都医科大学宣武医院。宣武医院陈彪教授正在与苹果合作开发帕金森病相关App,他的影像也出现在了发布会视频中。 ResearchKit是一款医疗研究平台,这款新的移动应用平台与去年6月发布的HealthKit一样,可以收集和分析用户的健康数据,成为

FDA批准Neuroderm新型帕金森药物输送系统进一步临床研究

帕金森症一直是困扰许多老年人的重大健康问题,而随着世界老龄化进程的加剧,帕金森症药物研发领域也日趋火爆。尽管目前还没有能够彻底治疗这种疾病的药物,但是levodopa、carbidopa等药物已经能在很大程度上改善帕金森症患者的健康状况。 最近,FDA宣布批准Neuroderm公司开发的帕金森症输送系统进行进一步的临床研究。这也意味着公司开发的适用于中度帕金森患者的ND0612L和重度帕金森

APD:帕金森氏症患者记忆力与心脑血管有关

帕金森氏症(PD)是一种渐进式神经退行性疾病,特点是拥有运动和非运动症状。根据帕金森氏症基金会的数据,全球有七百万到一千万人患有PD。在美国,每年有6000人诊断出患上帕金森氏症,男性患病的几率是女性的1.5倍。 PD通过与四个标志性运动症状有关:休息震颤、僵直、运动迟缓和姿势不稳。此外,相关的非运动症状包括五类:神经精神性、自主性、感官性、胃肠道和睡眠障碍。典型的帕金森氏症医疗还无法治疗这些对

艾伯维新药Duopa改善帕金森症患者病情

帕金森病(Parkinson's disease,PD)是一种常见的神经系统变性疾病,老年人多见,平均发病年龄为60岁左右。这种疾病最主要的病理改变是中脑黑质多巴胺(dopamine, DA)能神经元的变性死亡,由此而引起纹状体DA含量显着性减少而致病。导致这一病理改变的确切病因目前仍不清楚,遗传因素、环境因素、年龄老化、氧化应激等均可能参与PD多巴胺能神经元的变性死亡过程。 目前这一疾病一

可穿戴设备有望颠覆病诊疗帕金森

可穿戴设备样机 王守岩佩戴样机作为一个中国人,你大约不会知道这样一组数据:目前全球约有500万名帕金森病患者,而中国人占了47%。随着中国老龄化问题不断加剧,预计到2030年中国帕金森病患者数量将占到全球的57%。其中,中国城市里约有65%的帕金森病患者被误诊和漏诊,而农村地区该病的未被诊断率更是高达90%。最新的流行病学调查显示,目前城市65岁以上人群帕金森病患病率已经接近2%。这组看

Baidu
map
Baidu
map
Baidu
map